A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria
<br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions">Due to the widespread prevalence of resistant parasites, chloroquine (CQ) was removed from front-line antimalarial chemotherapy in the 1990s despite its initial promise of disease eradication. Since then, resistance-conferri...
Κύριοι συγγραφείς: | Ch'Ng, J, Mok, S, Bozdech, Z, Lear, M, Boudhar, A, Russell, B, Nosten, F, Tan, K |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Springer Nature
2013
|
Παρόμοια τεκμήρια
-
A whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria
ανά: Ch'ng, Jun-Hong, κ.ά.
Έκδοση: (2013) -
Overcoming chloroquine resistance in malaria: Design, synthesis and structure-activity relationships of novel chemoreversal agents.
ανά: Boudhar, A, κ.ά.
Έκδοση: (2016) -
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.
ανά: Ch'ng, J, κ.ά.
Έκδοση: (2014) -
Comparison of artemether and chloroquine for severe malaria in Gambian children.
ανά: White, N, κ.ά.
Έκδοση: (1992) -
Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in
Plasmodium vivax malaria
ανά: Chu, C, κ.ά.
Έκδοση: (2018)